Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
002694.SZ Stock Summary
Top 10 Correlated ETFs
002694.SZ
In the News
002694.SZ Financial details
Company Rating
Neutral
Market Cap
3.59B
Income
91.04M
Revenue
912.94M
Book val./share
0.29
Cash/share
0.13
Dividend
-
Dividend %
-
Employees
1.49K
Optionable
No
Shortable
Yes
Earnings
23 Apr 2021
P/E
35.93
Forward P/E
-
PEG
-3.12
P/S
4.96
P/B
20.72
P/C
33
P/FCF
-58.86
Quick Ratio
0.33
Current Ratio
0.67
Debt / Equity
1.29
LT Debt / Equity
0.21
-
-
EPS (TTM)
0.15
EPS next Y
-
EPS next Q
-
EPS this Y
-76%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
3.71%
Revenue last 5Y
-8.7%
Revenue Q/Q
-13.91%
EPS Q/Q
-101.32%
-
-
-
-
SMA20
-
SMA50
-16.67%
SMA100
-28.57%
Inst Own
-
Inst Trans
-
ROA
9%
ROE
104%
ROC
0.52%
Gross Margin
15%
Oper. Margin
14%
Profit Margin
10%
Payout
16%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
4.2-8.83
52W High
-46.38%
52W Low
+7.25%
RSI
33
Rel Volume
1.5
Avg Volume
5.33M
Volume
7.97M
Perf Week
-12.98%
Perf Month
-18.9%
Perf Quarter
-36.91%
Perf Half Y
-42.42%
-
-
-
-
Beta
0.335
-
-
Volatility
0.2%, 0.39%
Prev Close
-3.38%
Price
4.29
Change
1.42%
002694.SZ Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 2.88 | 2.78 | 2.39 | 2.5 | 1.77 | |
Net income per share | -0.2 | -0.02 | -0.5 | -1 | -0.24 | |
Operating cash flow per share | 0.24 | 0.41 | 0.34 | 0.02 | 0.07 | |
Free cash flow per share | -0.39 | 0.34 | 0.27 | -0.02 | 0.04 | |
Cash per share | 0.25 | 0.35 | 0.15 | 0.13 | 0.18 | |
Book value per share | 1.69 | 1.67 | 1.24 | 0.26 | 0.04 | |
Tangible book value per share | 1.45 | 1.41 | 0.97 | 0.02 | -0.21 | |
Share holders equity per share | 1.69 | 1.67 | 1.24 | 0.26 | 0.04 | |
Interest debt per share | 0.68 | 0.63 | 0.43 | 0.43 | 0.43 | |
Market cap | 2.42B | 1.92B | 1.53B | 2.68B | 2.82B | |
Enterprise value | 2.62B | 2.12B | 1.67B | 2.81B | 2.92B | |
P/E ratio | -20.9 | -158.45 | -5.13 | -4.49 | -19.75 | |
Price to sales ratio | 1.45 | 1.17 | 1.07 | 1.79 | 2.67 | |
POCF ratio | 17.74 | 7.98 | 7.46 | 211.65 | 67.8 | |
PFCF ratio | -10.75 | 9.49 | 9.52 | -291.9 | 118.09 | |
P/B Ratio | 2.48 | 1.94 | 2.07 | 17.21 | 126.69 | |
PTB ratio | 2.48 | 1.94 | 2.07 | 17.21 | 126.69 | |
EV to sales | 1.57 | 1.3 | 1.17 | 1.88 | 2.76 | |
Enterprise value over EBITDA | 45.7 | 11.78 | 16.01 | -45.41 | 182.95 | |
EV to operating cash flow | 19.19 | 8.84 | 8.16 | 222.19 | 70.19 | |
EV to free cash flow | -11.63 | 10.52 | 10.41 | -306.45 | 122.26 | |
Earnings yield | -0.05 | -0.01 | -0.19 | -0.22 | -0.05 | |
Free cash flow yield | -0.09 | 0.11 | 0.11 | 0 | 0.01 | |
Debt to equity | 0.35 | 0.35 | 0.31 | 1.37 | 9.26 | |
Debt to assets | 0.13 | 0.12 | 0.09 | 0.1 | 0.11 | |
Net debt to EBITDA | 3.45 | 1.14 | 1.36 | -2.16 | 6.25 | |
Current ratio | 0.78 | 0.57 | 0.47 | 0.42 | 0.37 | |
Interest coverage | -2.96 | 1.76 | -0.18 | -2.28 | -1.12 | |
Income quality | -0.98 | -19.86 | -0.69 | -0.02 | -0.29 | |
Dividend Yield | 0.02 | 0.01 | 0.02 | 0.01 | 0.01 | |
Payout ratio | -0.35 | -2.12 | -0.08 | -0.03 | -0.12 | |
Sales general and administrative to revenue | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | |
Research and developement to revenue | 0.03 | 0.03 | 0.04 | 0.04 | 0.04 | |
Intangibles to total assets | 0.09 | 0.08 | 0.08 | 0.08 | 0.09 | |
Capex to operating cash flow | -2.65 | -0.16 | -0.22 | -1.73 | -0.43 | |
Capex to revenue | -0.22 | -0.02 | -0.03 | -0.01 | -0.02 | |
Capex to depreciation | -3.77 | -0.32 | -0.41 | -0.22 | -0.25 | |
Stock based compensation to revenue | 0 | -0.01 | 0 | 0 | 0 | |
Graham number | 2.76 | 0.88 | 3.72 | 2.42 | 0.45 | |
ROIC | -0.11 | -0.04 | 0 | -0.26 | -0.23 | |
Return on tangible assets | -0.05 | 0 | -0.13 | -0.31 | -0.09 | |
Graham Net | -1.3 | -1.82 | -2 | -2.42 | -2.31 | |
Working capital | -334.81M | -773.45M | -873.04M | -986.01M | -1.08B | |
Tangible asset value | 837.79M | 830.93M | 581.53M | 12.15M | -123.25M | |
Net current asset value | -385.87M | -824.15M | -928.12M | -1.19B | -1.16B | |
Invested capital | 0.35 | 0.35 | 0.31 | 1.37 | 9.26 | |
Average receivables | 795.74M | 630.1M | 430.02M | 321.98M | 265.5M | |
Average payables | 235.59M | 478.07M | 677M | 694.14M | 769.42M | |
Average inventory | 290.68M | 303.79M | 316.6M | 302.54M | 286.61M | |
Days sales outstanding | 161.2 | 116.84 | 85.56 | 75.56 | 76.74 | |
Days payables outstanding | 67.35 | 197.81 | 203.13 | 201.13 | 324.22 | |
Days of inventory on hand | 74.54 | 91.62 | 95.98 | 81.1 | 111.67 | |
Receivables turnover | 2.26 | 3.12 | 4.27 | 4.83 | 4.76 | |
Payables turnover | 5.42 | 1.85 | 1.8 | 1.81 | 1.13 | |
Inventory turnover | 4.9 | 3.98 | 3.8 | 4.5 | 3.27 | |
ROE | -0.12 | -0.01 | -0.4 | -3.83 | -6.41 | |
Capex per share | -0.62 | -0.06 | -0.07 | -0.04 | -0.03 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q3
Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.46 | 0.38 | 0.31 | 0.45 | 0.42 | |
Net income per share | -0.03 | -0.07 | -0.02 | 0.25 | 0 | |
Operating cash flow per share | -0.03 | -0.07 | -0.02 | 0.03 | 0.03 | |
Free cash flow per share | -0.03 | -0.09 | -0.02 | 0.03 | 0.02 | |
Cash per share | 0.13 | 0.18 | 0.11 | 0.12 | 0.13 | |
Book value per share | 0.11 | 0.04 | 0.02 | 0.27 | 0.29 | |
Tangible book value per share | -0.13 | -0.21 | -0.22 | 0.09 | 0.1 | |
Share holders equity per share | 0.11 | 0.04 | 0.02 | 0.27 | 0.29 | |
Interest debt per share | 0.33 | 0.36 | 0.35 | 0.36 | 0.37 | |
Market cap | 2.81B | 2.82B | 2.99B | 3.79B | 3.96B | |
Enterprise value | 2.93B | 2.92B | 3.13B | 3.92B | 4.09B | |
P/E ratio | -40.12 | -16.11 | -61.75 | 6.36 | -539.39 | |
Price to sales ratio | 10.15 | 12.41 | 16.22 | 14.06 | 17.07 | |
POCF ratio | -160.49 | -64.43 | -247.01 | 197.88 | 274.68 | |
PFCF ratio | -159.61 | -50.24 | -206.2 | 231.18 | 362.95 | |
P/B Ratio | 42.32 | 126.69 | 271.78 | 23.7 | 25.07 | |
PTB ratio | 42.32 | 126.69 | 271.78 | 23.7 | 25.07 | |
EV to sales | 10.59 | 12.85 | 16.99 | 14.55 | 17.63 | |
Enterprise value over EBITDA | -256.88 | -169.02 | -472.39 | 24.01 | -981.82 | |
EV to operating cash flow | -167.44 | -66.71 | -258.78 | 204.83 | 283.63 | |
EV to free cash flow | -166.52 | -52.02 | -216.03 | 239.29 | 374.77 | |
Earnings yield | -0.01 | -0.02 | 0 | 0.04 | 0 | |
Free cash flow yield | -0.01 | -0.02 | 0 | 0 | 0 | |
Debt to equity | 2.96 | 9.26 | 18.71 | 1.27 | 1.29 | |
Debt to assets | 0.11 | 0.11 | 0.11 | 0.19 | 0.19 | |
Net debt to EBITDA | -10.66 | -5.78 | -21.49 | 0.81 | -30.95 | |
Current ratio | 0.37 | 0.37 | 0.36 | 0.67 | 0.67 | |
Interest coverage | 4.5 | -2.98 | -2.95 | 15.08 | -0.26 | |
Income quality | 1 | 1 | 1 | 0.13 | -7.85 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | -0.26 | -0.07 | -0.33 | 0.03 | -2.09 | |
Sales general and administrative to revenue | 0.18 | -0.17 | 0.1 | -0.02 | 0.16 | |
Research and developement to revenue | 0.03 | 0.05 | 0.04 | 0.03 | 0.03 | |
Intangibles to total assets | 0.09 | 0.09 | 0.09 | 0.11 | 0.11 | |
Capex to operating cash flow | 0.01 | 0.28 | 0.2 | -0.14 | -0.24 | |
Capex to revenue | 0 | -0.05 | -0.01 | -0.01 | -0.02 | |
Capex to depreciation | -0.01 | -0.7 | -0.2 | -0.23 | 0.15 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0.27 | 0.25 | 0.09 | 1.22 | 0.15 | |
ROIC | 0.03 | -0.09 | -0.06 | 0.45 | -0.01 | |
Return on tangible assets | -0.01 | -0.03 | -0.01 | 0.16 | 0 | |
Graham Net | -2.3 | -2.31 | -2.32 | -0.91 | -0.97 | |
Working capital | -1.07B | -1.08B | -1.08B | -272.97M | -266.85M | |
Tangible asset value | -78.79M | -123.25M | -133.48M | 53.8M | 54.27M | |
Net current asset value | -1.15B | -1.16B | -1.16B | -351.69M | -345.16M | |
Invested capital | 2.96 | 9.26 | 18.71 | 1.27 | 1.29 | |
Average receivables | 277.45M | 248.85M | 230.93M | 216.19M | 191.52M | |
Average payables | 824.52M | 811.44M | 804.64M | 443.61M | 84.51M | |
Average inventory | 277.04M | 270.02M | 283.04M | 287.24M | 283.12M | |
Days sales outstanding | 89.53 | 87.94 | 117.03 | 64.31 | 73.95 | |
Days payables outstanding | 318.85 | 381.58 | 460.85 | 32.18 | 39.8 | |
Days of inventory on hand | 102.44 | 131.43 | 165.49 | 111.59 | 128.88 | |
Receivables turnover | 1.01 | 1.02 | 0.77 | 1.4 | 1.22 | |
Payables turnover | 0.28 | 0.24 | 0.2 | 2.8 | 2.26 | |
Inventory turnover | 0.88 | 0.68 | 0.54 | 0.81 | 0.7 | |
ROE | -0.26 | -1.97 | -1.1 | 0.93 | -0.01 | |
Capex per share | 0 | -0.02 | 0 | 0 | -0.01 |
002694.SZ Frequently Asked Questions
What is Goody Science&Technology Co.,Ltd stock symbol ?
Goody Science&Technology Co.,Ltd is a CN stock and trading under the symbol 002694.SZ
What is Goody Science&Technology Co.,Ltd stock quote today ?
Goody Science&Technology Co.,Ltd stock price is $4.29 today.
Is Goody Science&Technology Co.,Ltd stock public?
Yes, Goody Science&Technology Co.,Ltd is a publicly traded company.